Novitium Pharma LLC: Drug Recall
Recall #D-0389-2024 · 03/04/2024
Class III: Low Risk
Recall Details
- Recall Number
- D-0389-2024
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Novitium Pharma LLC
- Status
- Terminated
- Date Initiated
- 03/04/2024
- Location
- East Windsor, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,940 1000-count bottles
Reason for Recall
Cross Contamination with Other Products:(mycophenolate mofetil).
Product Description
Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20
Distribution Pattern
Nationwide in the USA
Other Recalls by Novitium Pharma LLC
- Class III: Low Risk 03/25/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.